Skip to content

Population Pharmacokinetics of Meropenem in Critically Ill Infant Patients

Population Pharmacokinetics of Meropenem in Critically Ill Infant Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20191106001
Enrollment
40
Registered
2019-11-06
Start date
2020-02-04
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically ill infant patients Critically ill infant patients Bacterial Infections Meropenem

Interventions

Antibiotic
Experimental Drug
meropenem

Sponsors

The 90th Anniversary of Chulalongkorn University Fund
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Months to 2 Years

Inclusion criteria

Inclusion criteria: 1. Patients were aged 1 month - 2 years 2. Patients admitted to pediatrics intensive care unit (PICU) or patients admitted to outside the PICU that they were criteria as follows - Patients had been diagnosed with sepsis - Patients had been diagnosed with septic shock - Patients had quick SOFA scores ≥ 2 while receiving the meropenem - Patients were receiving vasopressor drug while receiving the meropenem - Patients used invasive mechanical ventilation while receiving the meropenem 3. Patients were receiving meropenem therapy

Exclusion criteria

Exclusion criteria: 1. Patients had meropenem allergy or history meropenem allergy 2. Patients had weight lower 3 kilograms 3. Patients had preterm birth history 4. Patients had creatinine clearance < 50 ml/min/1.73 m2 5. Patients were receiving renal replacement therapy or kidney transplant 6. Patients were receiving drug interaction with meropenem that valproic acid and probenecid 7. Parent of infant patients did not consent to attend research or patients did not have childcare obviously

Design outcomes

Primary

MeasureTime frame
Pharmacokinetic parameters of population 0.5 or 1 or 3 h&#44; 2&#44; 4&#44; 6 and 8 h Blood for meropenem level

Secondary

MeasureTime frame
Severe oxygen desaturation During intubation Pulse oximetry < 80%,Lowest oxygen saturation During intubation up to 2 minutes after successful intubation Pulse oximetry,Hypotension that requires treatment with medication or fluid During intubation Blood pressure measurement,Bradycardia that requires medication During intubation Electrocardiogram monitoring,Cardiac arrest During intubation Electrocardiogram monitoring,Air leak syndrome During and immediately after intubation Chest X&#45;ray showing pneumothorax&#44; pneumomediastinum or pneumoperitoneum,Abdominal distention During and immediately after intubation Physical exam

Countries

Thailand

Contacts

Public ContactWanlika Yonwises

Faculty of Pharmaceutical Sciences&#44; Chulalongkorn university

liquidkung.wyp@gmail.com+669-359-36295

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026